Apixaban F.C. Tabs 2.5mg/tab & 5mg/tab (under development)

Product description

Apixaban Film Coated Tablets 2.5mg & 5mg
Reference Product: Eliquis® / Bristol-Myers Squibb/Pfizer
Description: Prevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation (NVAF), with one or more risk factors, such as prior stroke or transient ischaemic attack (TIA); age≥ 75 years; hypertension; diabetes mellitus; symptomatic heart failure (NYHA Class ≥ II).Treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and prevention of recurrent DVT and PE in adults  for haemodynamically unstable PE patients.
Dossier Status: On-going 
Stability Studies: Zone II / Zone IVb
Shelf life (Originator): Three (3) years
Batch Size: To be defined
Pack Sizes: To be defined / Originator pack: BT x 14, 20, 28, 56, 60, 168 and 200 film-coated tablets
Read more

Specifications

Categories Pharmaceutical Products / ATC codingBlood and Blood Forming Organs; Finished Dosage FormsOut-licensing; Finished Dosage FormsTablets
Sales markets Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Africa; Central America (e.g. Mexico); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South East Asia (e.g. Thailand, Philippines, Singapore)
Supplied from Greece

More products from ANFARM HELLAS S.A.

View all our products (37)
Apixaban F.C. Tabs 2.5mg/tab & 5mg/tab (under development)

Contact information

Address

Telephone

Website

View all contact information
Customized drug delivery from technology to therapy

Customized drug delivery from technology to therapy

Your innovation. Our ability to bring it to market.

Your innovation. Our ability to bring it to market.

CONTENT GROUP

CONTENT GROUP

Wavelength Pharmaceuticals

Wavelength Pharmaceuticals

Discover Aptar Pharma, the go-to drug delivery expert

Discover Aptar Pharma, the go-to drug delivery expert